InvestorsHub Logo
Followers 0
Posts 1586
Boards Moderated 1
Alias Born 06/25/2019

Re: EmeraldSEA post# 6338

Friday, 08/14/2020 6:19:51 PM

Friday, August 14, 2020 6:19:51 PM

Post# of 6773
Amercanex Integration.

You said, " Mgmt has not spoken about the progress of next-gen biotrack, americanex or analytics"

I found this excerpt (some sections removed) to be highly interesting.

We have largely completed the financial and operational integrations of the previous 24 months, namely the acquisitions of BioTrackTHC, Engeni, Tan Security and Amercanex...

... Engeni has also become the Company’s organic offshore software development platform, and has delivered the second generation of the BioTrackTHC software...

...The Company has integrated Amercanex’s technology with BioTrackTHC’s software platforms. Integration of the previously announced acquisitions has already yielded the operational and financial results that the management team sought, evidenced by strongly improved cash flows from operations, growing market share, and a greatly accelerated software development time with increased market responsiveness.

These integrations still have room to yield more financial and operational leverage, which will be welcome in the unprecedented operating environment that now confronts the industry. Further, the turnaround of the BioTrackTHC unit is well advanced, with strategic restructuring in operations and personnel nearly complete, having been initiated in 2019. The transition of BioTrackTHC from an operation with negative $800,000 of Adjusted EBITDA in 2018 (while still better than competitors) into an operation that generated nearly $800,000 in Adjusted EBITDA in Q1 2020 and Q2 2020 is a transformational success.


Fascinating!

Of course, Tan was part of Helix Security and was sold. I like this company. I just don't like that conversion loss in the statement of cash flows. I don't like this price for conversions. But at the same time, it gave me a 40,000 share position at average of cost of .29.

As for your cannalytics, which I'm curious about too, it also says this in there:

Lastly, the Company generates monthly recurring revenues from Cannalytics, its business intelligence and data tool for commercial customers. Revenue is recognized monthly.

There is nothing else in there about it. I don't know how to break that out. That's a good question to add right there!

I'm going to have to move that question up to the top. If they go in order of priority, I want that to be addressed. Form 4's at the bottom. Sorry, no offense.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.